| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 23578-45-2 | N-甲基丙烯酰基甘氨酸; N-甲基丙烯酰基氨基乙酸 | N-Methacryloylglycine; Glycine,N-(2-methyl-1-oxo-2-propenyl)- (9CI); Glycine, N-methacryloyl- (6CI,8CI); Methacryloylaminoacetic acid; Methacryloylglycine; N-(Methylacryloyl)glycine; |  | C6H9NO3 | 詳情 | 供應(yīng)商 |
| 64967-39-1 | N-[3-(2-呋喃基)丙烯酰]-L-苯丙氨酰-甘氨酰-甘氨酸 | N-[3-(2-Furyl)acryloyl]-L-phenylalanyl-glycyl-glycine; N-[3-(2-Furyl)acryloyl]-Phe-Gly-Gly |  | C20H21N3O6 | 詳情 | 供應(yīng)商 |
| 69416-61-1 | (R)-4-羥基-2-[3-甲氧基-1-甲基-3-氧代-1-丙烯基氨基]-單鉀鹽苯乙酸; 左旋對羥基苯甘氨酸甲基鄧鉀鹽; D(-)-4- | 2[[(1e)-2-(methoxycarbonyl)-1-methylvinyl]amino]- (2r)-2-(4-hydroxyphenyl)acetic acid; D-p-Hydroxyphenylglycine methyl patassium Dane; hydroxyphenylglycine,dane salt |  | C13H14NO5K | 詳情 | 供應(yīng)商 |
| 117858-54-5 | 聚丙烯酰胺3-半胱氨酸甘氨酸羥基 | Glycine,S-[2,3-bis[(1-oxohexadecyl)oxy]propyl]-N-(1-oxohexadecyl)-L-cysteinyl-L-alanyl-; Glycine,N-[N-[S-[2,3-bis[(1-oxohexadecyl)oxy]propyl]-N-(1-oxohexadecyl)-L-cysteinyl]-L-alanyl]- |  | C59H111N3O9S | 詳情 | 供應(yīng)商 |
| 26400-33-9 | N-(3-[2-呋喃]丙烯)甘氨酸亮酰胺 | L-Leucinamide,N-[3-(2-furanyl)-1-oxo-2-propen-1-yl]glycyl-; 2-Furanacrylamide,N-[[(1-carbamoyl-3-methylbutyl)carbamoyl]methyl]-, L- (8CI); L-Leucinamide,N-[3-(2-furanyl)-1-oxo-2-propenyl]glycyl- (9CI); Leucinamide,N-[3-(2-furyl)acryloyl]glycyl-, L- (8CI); 3-(2-Furylacryloyl)glycyl-L-leucineamide; FAGLA; Furacryloylglycyl-L-leucinamide; Furylacryloylglycyl-L-leucinamide; N-3-(2-Furyl)acryloylglycyl-L-leucinaminde; N-Furylacryloylglycyl-L-leucinamide; NSC 334344 |  | C15H21N3O4 | 詳情 | 供應(yīng)商 |
| 64566-61-6 | N-[3-(2-呋喃基)丙烯酰]-L-苯丙氨酰甘氨酰甘氨酸 | FAPGG; FA-PHE-GLY-GLY-OH; FAPGG; 3-(2-FURYL)ACRYLOYL-PHE-GLY-GLY-OH; 3-(2-FURYLACRYLOYL)-L-PHE-GLY-GLY; ANGIOTENSIN-CONVERTING ENZYME SUBSTRATE; N-[3-(2-FURYLACRYLOYL)]-L-PHENYLALANINE-GLYCL-GLYCINE; arginine-glycine-proline-phenylalanine-proline-isoleucine |  | C20H21N3O6 | 詳情 | 供應(yīng)商 |